Yarrow Bioscience Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Yarrow Bioscience Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- YARW
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001566044
Board of directors
-
Anthony D. Bruno · DirectorSince 2023
-
Christine Borowski · DirectorSince 2023
-
David Domzalski · Director · PRESIDENT AND CEOSince 2023
-
Elisabeth Sandoval · DirectorSince 2023
-
Patrick G. Lepore · DirectorSince 2023
-
Sharon Barbari · DirectorSince 2023
-
Steven L. Basta · DirectorSince 2023
Chief executives
David Domzalski
· President and CEO
Dates unknown
Board connections
1 of this board's directors also sit on 1 other board.
- via Elisabeth Sandoval
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 31, 2024 | David Domzalski Director, Officer (PRESIDENT AND CEO) | Grant or award | +4,429 | $2.16 | $9,567 |
| Apr 1, 2024 | Zeronda Tyler Officer (CHIEF FINANCIAL OFFICER) | Shares withheld for tax | −94 | $3.08 | $290 |
| Apr 1, 2024 | Stuart Iain Officer (CHIEF SCIENTIFIC OFFICER) | Shares withheld for tax | −157 | $3.08 | $484 |
| Apr 1, 2024 | Harsch Mutya Officer (CHIEF LEGAL OFFICER AND GC) | Shares withheld for tax | −161 | $3.08 | $496 |
| Apr 1, 2024 | David Domzalski Director, Officer (PRESIDENT AND CEO) | Shares withheld for tax | −1,004 | $3.08 | $3,092 |
| Jan 2, 2024 | Zeronda Tyler Officer (Chief Financial Officer) | Shares withheld for tax | −93 | $2.28 | $212 |
| Jan 2, 2024 | Stuart Iain Officer (Chief Scientific Officer) | Shares withheld for tax | −157 | $2.28 | $358 |
| Jan 2, 2024 | Harsch Mutya Officer (Chief Legal Officer and GC) | Shares withheld for tax | −161 | $2.28 | $367 |
| Jan 2, 2024 | David Domzalski Director, Officer (President and CEO) | Shares withheld for tax | −1,004 | $2.28 | $2,289 |
| Jan 1, 2024 | Zeronda Tyler Officer (Chief Financial Officer) | Grant or award | +62,500 | — | — |
| Jan 1, 2024 | Stuart Iain Officer (Chief Scientific Officer) | Grant or award | +62,500 | — | — |
| Jan 1, 2024 | Harsch Mutya Officer (Chief Legal Officer and GC) | Grant or award | +62,500 | — | — |
| Jan 1, 2024 | David Domzalski Director, Officer (President and CEO) | Grant or award | +225,000 | — | — |
| Dec 13, 2023 | Zeronda Tyler Officer (Chief Financial Officer) | Grant or award | +62,500 | — | — |
| Dec 13, 2023 | Stuart Iain Officer (Chief Scientific Officer) | Grant or award | +62,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.